
The nutraceutical products, to be sold under the 4 umbrella brands, would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies, Cipla said in a regulatory filing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2SsE95t
via
IFTTT
0 comments:
Post a Comment